Liliemark J, Pettersson B, Engberg B, Lafolie P, Masquelier M, Peterson C
Department of Medicine, Karolinska Institute at Huddinge Hospital, Sweden.
Cancer Res. 1990 Jan 1;50(1):108-12.
The intracellular metabolism of 6-mercaptopurine (6-MP) was studied in a murine leukemia cell line, WEHI-3b. Cells were incubated 3 to 24 h with 10 nM to 50 microM 6-MP. Nucleotides were extracted with perchloric acid, and the 6-thiopurine nucleotides were isolated on mercurial cellulose. The endogenous ribonucleotides in the perchloric acid extracts as well as 6-thiopurine nucleotides were separated and quantified with anion exchange high-performance liquid chromatography. The concentration of 6-thioinosinate (6-TIMP) and 6-thioxantinate (6-TXMP) increased with an increasing 6-MP dose. The concentration of the 6-thioguanosine nucleotides (6-TGN) increased with 6-MP concentrations between 10 nM and 1 microM. However, further increase in 6-MP concentration led to a decrease in the formation of 6-TGN. At 50 microM 6-MP, the concentration of 6-thioguanosine 5'-triphosphate was one fifth of that seen at 1 microM. The incorporation of 6-[35S]mercaptopurine into DNA was also slightly higher at 1 microM compared with 50 microM. The cytocidal effect on clonogenic cells was one log greater at 1 microM 6-MP compared with 50 microM 6-MP. The decrease of 6-TGN was accompanied not only by an increased 6-TIMP concentration but also by an inhibition of the purine de novo synthesis and consequently by a decrease of the cellular ATP concentration. The ATP concentration in the cells treated with 1 microM 6-MP could be reduced to the level seen in cells treated with 50 microM 6-MP by simultaneous incubation with 0.3 microM antimycin A. This decrease of ATP concentration was accompanied by a reduction of 6-TGN and to a lesser extent of 6-TXMP. These experiments suggest that the "self-limiting" phenomenon in the metabolism of 6-MP might be caused by a depletion of ATP by inhibition of purine de novo synthesis presumably by 6-TIMP.
在小鼠白血病细胞系WEHI-3b中研究了6-巯基嘌呤(6-MP)的细胞内代谢。细胞用10 nM至50 μM的6-MP孵育3至24小时。用高氯酸提取核苷酸,并用汞纤维素分离6-硫代嘌呤核苷酸。用阴离子交换高效液相色谱法分离并定量高氯酸提取物中的内源性核糖核苷酸以及6-硫代嘌呤核苷酸。6-硫代次黄嘌呤核苷酸(6-TIMP)和6-硫代黄嘌呤核苷酸(6-TXMP)的浓度随6-MP剂量的增加而增加。6-硫代鸟苷核苷酸(6-TGN)的浓度在6-MP浓度为10 nM至1 μM时增加。然而,6-MP浓度的进一步增加导致6-TGN的形成减少。在50 μM 6-MP时,6-硫代鸟苷5'-三磷酸的浓度是1 μM时的五分之一。与50 μM相比,1 μM时6-[35S]巯基嘌呤掺入DNA的量也略高。与50 μM 6-MP相比,1 μM 6-MP对克隆形成细胞的杀伤作用大一个对数级。6-TGN的减少不仅伴随着6-TIMP浓度的增加,还伴随着嘌呤从头合成的抑制,进而导致细胞ATP浓度的降低。通过与0.3 μM抗霉素A同时孵育,用1 μM 6-MP处理的细胞中的ATP浓度可降低至用50 μM 6-MP处理的细胞中的水平。ATP浓度的这种降低伴随着6-TGN的减少以及程度较轻的6-TXMP的减少。这些实验表明,6-MP代谢中的“自我限制”现象可能是由于嘌呤从头合成受到抑制(可能是由6-TIMP引起)导致ATP耗竭所致。